| 09/Mar/2020 | 30049089 | HERTICAD biological product 150mg (HC: Trastuzumab). Box of 1 vial of lyophilized powder mixed with intravenous solution. Visa: QLSP-H03-1176-19. SL: 402030219; NSX: February 4, 2019; HD: February 1, 2023 | Russian Federation | pack/ box / bag / package | 71.00 | 25,063.00 | 353.00 | View Importer | View Supplier |
| 09/Mar/2020 | 30049089 | HERTICAD biological product 150mg (HC: Trastuzumab). Box of 1 vial of lyophilized powder mixed with intravenous solution. Visa: QLSP-H03-1176-19. SL: 402040719; NSX: July 25, 2019; HD: July 1, 2023 | Russian Federation | pack/ box / bag / package | 229.00 | 80,837.00 | 353.00 | View Importer | View Supplier |
| 09/Mar/2020 | 30049089 | HERTICAD Biological Products 440mg (HC: Trastuzumab). Box of 1 vial of lyophilized powder mixed with intravenous solution + 1 vial of 20ml solvent. Visa: QLSP-H03-1177-19.SL:402050619; NSX: June 18, 2019; HD: June 1, 2023 | Russian Federation | pack/ box / bag / package | 200.00 | 199,200.00 | 996.00 | View Importer | View Supplier |
| 09/Mar/2020 | 30049089 | HERTICAD Biological Products 440mg (HC: Trastuzumab). Box of 1 vial of lyophilized powder mixed with intravenous solution + 1 vial of 20ml solvent. Visa: QLSP-H03-1177-19.SL:402050619; NSX: June 18, 2019; HD: June 1, 2023 | Russian Federation | pack/ box / bag / package | 700.00 | 697,200.00 | 996.00 | View Importer | View Supplier |
| 09/Mar/2020 | 30049089 | HERTICAD biological product 150mg (HC: Trastuzumab). Box of 1 vial of lyophilized powder mixed with intravenous solution. Visa: QLSP-H03-1176-19. SL: 402040719; NSX: July 25, 2019; HD: July 1, 2023 | Russian Federation | pack/ box / bag / package | 500.00 | 176,500.00 | 353.00 | View Importer | View Supplier |
